AwardTape · Defense awards · Beyond Barriers Therapeutics, Inc
Beyond Barriers Therapeutics, Inc: $879K in DoD and DHS awards
Beyond Barriers Therapeutics, Inc holds 1 DoD and DHS prime award with $879K obligated Jan 16, 2024 to Jan 13, 2026. Largest category: Health R&D at $879K; largest buyer: Defense Health Agency at $879K.
| Obligated FY2024+ | $879K |
|---|---|
| Awards | 1 |
| FY2024 | $879K |
| FY2025 | $0 |
| FY2026 to date | $0 |
| Lifetime obligated on these awards | $1.9M |
| Parent company (as reported) | Beyond Barriers Therapeutics, Inc |
| First and latest action | Jan 16, 2024 · Jan 13, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Health R&D | $879K | 1 awards | 100% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Defense Health Agency | $879K | 1 awards | 100% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| HT942523C0036 definitive contract | $879K | Intranasal treatment for mild traumatic brain injury (broad agency announcement number so190192) | Defense Health Agency | Health R&D | Jan 13, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial